{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:15:59Z","timestamp":1791152159412,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T00:00:00Z","timestamp":1407456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T00:00:00Z","timestamp":1407456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms5654","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T14:22:39Z","timestamp":1407507759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations"],"prefix":"10.1038","volume":"5","author":[{"given":"Sergey I.","family":"Nikolaev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Garieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Falconnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Ribaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Guipponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Groet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Giarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Nizetic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos E.","family":"Antonarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,8]]},"reference":[{"key":"BFncomms5654_CR1","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","volume":"381","author":"H Inaba","year":"2013","unstructured":"Inaba, H., Greaves, M. & Mullighan, C. G. Acute lymphoblastic leukaemia. Lancet 381, 1943\u20131955 (2013).","journal-title":"Lancet"},{"key":"BFncomms5654_CR2","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui, C. H., Robison, L. L. & Look, A. T. Acute lymphoblastic leukaemia. Lancet 371, 1030\u20131043 (2008).","journal-title":"Lancet"},{"key":"BFncomms5654_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","volume":"355","author":"H Hasle","year":"2000","unstructured":"Hasle, H., Clemmensen, I. H. & Mikkelsen, M. Risks of leukaemia and solid tumours in individuals with Down\u2019s syndrome. Lancet 355, 165\u2013169 (2000).","journal-title":"Lancet"},{"key":"BFncomms5654_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archpedi.1957.04030040075012","volume":"94","author":"W Krivit","year":"1957","unstructured":"Krivit, W. & Good, R. A. Simultaneous occurrence of mongolism and leukemia; report of a nationwide survey. AMA J. Dis. Child. 94, 289\u2013293 (1957).","journal-title":"AMA J. Dis. Child."},{"key":"BFncomms5654_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/08880019209018329","volume":"9","author":"A Zipursky","year":"1992","unstructured":"Zipursky, A., Poon, A. & Doyle, J. Leukemia in Down syndrome: a review. Pediatr. Hematol. Oncol. 9, 139\u2013149 (1992).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"BFncomms5654_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.leu.2402765","volume":"17","author":"H Hasle","year":"2003","unstructured":"Hasle, H. et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 17, 277\u2013282 (2003).","journal-title":"Leukemia"},{"key":"BFncomms5654_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/S0140-6736(03)13266-7","volume":"361","author":"J Groet","year":"2003","unstructured":"Groet, J. et al. Acquired mutations in GATA1 in neonates with Down\u2019s syndrome with transient myeloid disorder. Lancet 361, 1617\u20131620 (2003).","journal-title":"Lancet"},{"key":"BFncomms5654_CR8","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1182\/blood-2008-11-163501","volume":"113","author":"S Malinge","year":"2009","unstructured":"Malinge, S., Izraeli, S. & Crispino, J. D. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 113, 2619\u20132628 (2009).","journal-title":"Blood"},{"key":"BFncomms5654_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng955","volume":"32","author":"J Wechsler","year":"2002","unstructured":"Wechsler, J. et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 32, 148\u2013152 (2002).","journal-title":"Nat. Genet."},{"key":"BFncomms5654_CR10","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","volume":"372","author":"D Bercovich","year":"2008","unstructured":"Bercovich, D. et al. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down\u2019s syndrome. Lancet 372, 1484\u20131492 (2008).","journal-title":"Lancet"},{"key":"BFncomms5654_CR11","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","volume":"115","author":"L Hertzberg","year":"2010","unstructured":"Hertzberg, L. et al. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood 115, 1006\u20131017 (2010).","journal-title":"Blood"},{"key":"BFncomms5654_CR12","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1182\/blood-2008-08-170928","volume":"113","author":"L Kearney","year":"2009","unstructured":"Kearney, L. et al. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood 113, 646\u2013648 (2009).","journal-title":"Blood"},{"key":"BFncomms5654_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/ng.469","volume":"41","author":"CG Mullighan","year":"2009","unstructured":"Mullighan, C. G. et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat. Genet. 41, 1243\u20131246 (2009).","journal-title":"Nat. Genet."},{"key":"BFncomms5654_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1182\/blood-2013-06-509463","volume":"123","author":"TD Buitenkamp","year":"2014","unstructured":"Buitenkamp, T. D. et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood 123, 70\u201377 (2014).","journal-title":"Blood"},{"key":"BFncomms5654_CR15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/ng.2532","volume":"45","author":"L Holmfeldt","year":"2013","unstructured":"Holmfeldt, L. et al. The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat. Genet. 45, 242\u2013252 (2013).","journal-title":"Nat. Genet."},{"key":"BFncomms5654_CR16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1182\/blood-2013-03-491936","volume":"122","author":"SI Nikolaev","year":"2013","unstructured":"Nikolaev, S. I. et al. Exome sequencing identifies putative drivers of progression of transient myeloproliferative disorder to AMKL in infants with Down syndrome. Blood 122, 554\u2013561 (2013).","journal-title":"Blood"},{"key":"BFncomms5654_CR17","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","volume":"150","author":"JS Welch","year":"2012","unstructured":"Welch, J. S. et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264\u2013278 (2012).","journal-title":"Cell"},{"key":"BFncomms5654_CR18","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/ng.2759","volume":"45","author":"K Yoshida","year":"2013","unstructured":"Yoshida, K. et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat. Genet. 45, 1293\u20131299 (2013).","journal-title":"Nat. Genet."},{"key":"BFncomms5654_CR19","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/leu.2013.90","volume":"27","author":"V Grossmann","year":"2013","unstructured":"Grossmann, V. et al. High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia. Leukemia 27, 1933\u20131936 (2013).","journal-title":"Leukemia"},{"key":"BFncomms5654_CR20","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.1158\/0008-5472.CAN-08-0101","volume":"68","author":"M Case","year":"2008","unstructured":"Case, M. et al. Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia. Cancer. Res. 68, 6803\u20136809 (2008).","journal-title":"Cancer. Res."},{"key":"BFncomms5654_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ng.2874","volume":"46","author":"E Papaemmanuil","year":"2014","unstructured":"Papaemmanuil, E. et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat. Genet. 46, 116\u2013125 (2014).","journal-title":"Nat. Genet."},{"key":"BFncomms5654_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1182\/blood.V99.1.245","volume":"99","author":"CM Zwaan","year":"2002","unstructured":"Zwaan, C. M. et al. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome. Blood 99, 245\u2013251 (2002).","journal-title":"Blood"},{"key":"BFncomms5654_CR23","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1182\/blood-2009-07-235291","volume":"116","author":"KW Maloney","year":"2010","unstructured":"Maloney, K. W. et al. Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children\u2019s Oncology Group. Blood 116, 1045\u20131050 (2010).","journal-title":"Blood"},{"key":"BFncomms5654_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc3355","volume":"12","author":"D Nizetic","year":"2012","unstructured":"Nizetic, D. & Groet, J. Tumorigenesis in Down\u2019s syndrome: big lessons from a small chromosome. Nat. Rev. Cancer 12, 721\u2013732 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms5654_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/leu.2012.199","volume":"27","author":"TD Buitenkamp","year":"2013","unstructured":"Buitenkamp, T. D. et al. BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia. Leukemia 27, 251\u2013252 (2013).","journal-title":"Leukemia"},{"key":"BFncomms5654_CR26","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1182\/blood-2012-07-443218","volume":"120","author":"M Morak","year":"2012","unstructured":"Morak, M. et al. Small sizes and indolent evolutionary dynamics challenge the potential role of P2RY8-CRLF2-harboring clones as main relapse-driving force in childhood ALL. Blood 120, 5134\u20135142 (2012).","journal-title":"Blood"},{"key":"BFncomms5654_CR27","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 118, 3080\u20133087 (2011).","journal-title":"Blood"},{"key":"BFncomms5654_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2109","volume":"7","author":"S Schubbert","year":"2007","unstructured":"Schubbert, S., Shannon, K. & Bollag, G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7, 295\u2013308 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms5654_CR29","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature12248","volume":"497","author":"NM Baker","year":"2013","unstructured":"Baker, N. M. & Der, C. J. Cancer: Drug for an 'undruggable' protein. Nature 497, 577\u2013578 (2013).","journal-title":"Nature"},{"key":"BFncomms5654_CR30","doi-asserted-by":"publisher","first-page":"6279","DOI":"10.1158\/0008-5472.CAN-12-3869","volume":"72","author":"SI Nikolaev","year":"2012","unstructured":"Nikolaev, S. I. et al. A single-nucleotide substitution mutator phenotype revealed by exome sequencing of human colon adenomas. Cancer Res. 72, 6279\u20136289 (2012).","journal-title":"Cancer Res."},{"key":"BFncomms5654_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495\u2013501 (2014).","journal-title":"Nature"},{"key":"BFncomms5654_CR32","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms5654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms5654","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms5654.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T03:12:42Z","timestamp":1672974762000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms5654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFncomms5654"],"URL":"https:\/\/doi.org\/10.1038\/ncomms5654","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,8]]},"assertion":[{"value":"20 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4654"}}